The Effect of Rimonabant on Energy Expenditure, Fat Metabolism and Body Composition
Status:
Terminated
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This study will determine in obese subjects the direct effects of the weight loss drug
rimonabant (ie independent of weight loss) on energy expenditure, fat metabolism and and body
fat distribution. We hypothesise that rimonabant will increase energy expenditure. The fuel
for the increased energy expenditure will come from fat. As a result of burning more fat
there will be a decrease in fat in blood and an improvement in the body's response to
insulin.
Phase:
Phase 4
Details
Lead Sponsor:
University of Surrey
Collaborators:
European Foundation for the Study of Diabetes Royal Surrey County Hospital Royal Surrey County Hospital NHS Foundation Trust